Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Multi-Component Breath Alcohol Intervention Phase 3

NCT: NCT06994962 · RECRUITING

NCT IDNCT06994962
StatusRECRUITING
Start Date2025-05-01
Completion2027-01-31

Brief Summary

This is the third stage of a three-stage, NIH-funded study to develop and test a multi-modal intervention concerning blood/breath alcohol concentration for young adults who drink heavily. The multimodal intervention will be made up of brief telehealth counseling and psychoeducation and use of three existing mobile technologies. The brief counseling/psychoeducation and mobile technologies provide personalized feedback regarding blood or breath alcohol content. The long-term goal of use of these mobile technologies will be to facilitate moderate drinking. However, the main goals of the proposed research are to learn more about feasibility of our procedures, perceived value of the technologies and ease of use from the research participants' points of view. In this third stage of the study, the investigators will conduct a randomized controlled trial building on the formative research conducted in Stages 1 and 2.

Frequently Asked Questions

What is Multi-Component Breath Alcohol Intervention Phase 3?

Multi-Component Breath Alcohol Intervention Phase 3 is a clinical trial registered under NCT06994962. Current status: RECRUITING.

What is the status of NCT06994962?

The current status of NCT06994962 (Multi-Component Breath Alcohol Intervention Phase 3) is: RECRUITING.

When did Multi-Component Breath Alcohol Intervention Phase 3 start?

Multi-Component Breath Alcohol Intervention Phase 3 started on 2025-05-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.